INDUCED PLURIPOTENT STEM CELL-DERIVED CARDIOMYOCYTES FROM A PATIENT CARRYING AN UNPRECEDENTED VARIANT IN THE PRKAG2 GENE SHOW GLYCOGEN STORAGE AND ARE PROMISING TOOLS FOR THE IN VITRO STUDY OF THE METABOLIC CARDIOMYOPATHY